- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01771055
Direct Peritoneal Resuscitation Effects in the Damage Control Patient
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Standard methods of controlling bleeding and increasing blood flow to vital organs will be used. These methods include giving blood and fluids and surgically repairing the vessels that are causing the bleeding which are standard ways physicians treat injuries with massive blood loss. A drain (a small plastic tube) will be placed inside the belly.
Subjects will randomly (like flipping a coin) be placed into a group of patients who either get a sugar solution dripped into the belly after surgery or do not get this treatment. The drain will be used to drip a high glucose solution into the abdomen in patients be part of that group. The fluid will continue to be dripped into the belly until it is possible to close the skin and underlying layers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All trauma patients age 18 years or greater with massive blood loss
- Patients requiring a damage control procedure
- Traumatic injury within the last 24 hours
Exclusion Criteria:
- Patients who are pregnant
- Less than 18 years of age
- Known chronic renal disease
- Moribund
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Galactose
|
Galactose dripped into the abdomen after surgery
|
|
Placebo Comparator: Standard resuscitation
Standard surgical methods of controlling bleeding
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Morbidity
Time Frame: 1 Month
|
Evaluate the Number of participants with Morbidity receiving Direct Peritoneal Resuscitation versus those receiving standard care.
|
1 Month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jason Smith, MD, University of Louisville
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.0178
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Injury
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Göteborg UniversityInstitute of Aviation Medicine, Oslo, Norway; Naval Health Research Center; Fraunhofer... and other collaboratorsEnrolling by invitationTraumatic Injury of Spine | Traumatic Head Injury | Traumatic InjuriesSweden
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Daewon Pharmaceutical Co., Ltd.UnknownAcute Traumatic InjuryKorea, Republic of
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders... and other collaboratorsRecruitingTBI (Traumatic Brain Injury) | TBI | Traumatic Brain Injury With Loss of Consciousness | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
Poitiers University HospitalCompletedMild Traumatic Injury | Pre-hospital Dispatching | VisioconferenceFrance
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedProtein Feeding in Post-traumatic Injury PatientsUnited States
Clinical Trials on Galactose
-
Children's National Research InstituteNational Kidney FoundationCompletedFocal Segmental Glomerulosclerosis | Steroid Resistant Nephrotic SyndromeUnited States
-
University of BirminghamDairy Management Inc.Completed
-
Hospital Ruber InternacionalRecruitingRefractory Epilepsy | SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationSpain
-
University of BathCompletedLipemia | Cardiovascular Risk FactorUnited Kingdom
-
Insel Gruppe AG, University Hospital BernUniversity of Zurich; University Hospital Heidelberg; Medical University Innsbruck and other collaboratorsRecruitingGlycogen Storage Disease Type ISwitzerland
-
Eva Morava-KoziczChildren's Hospital of PhiladelphiaNot yet recruitingPGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of GlycosylationUnited States
-
Glostrup University Hospital, CopenhagenTerminatedDiabetic Macular OedemaDenmark
-
Tulane UniversityCompletedCongenital Disorders of GlycosylationUnited States
-
University of BathUniversity of Birmingham; Arla FoodsRecruiting
-
Eva Morava-KoziczChildren's Hospital of Philadelphia; National Institute of Neurological Disorders... and other collaboratorsNot yet recruitingSLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationUnited States